Myseum.AI Amends ATM, Reports $3.3M in Sales & Authorizes Additional $2.75M Equity Offering
Summary
Myseum.AI, Inc. has amended its At-The-Market (ATM) equity offering program, reporting $3.3 million in shares already sold and authorizing the sale of an additional $2.75 million in common stock.
Key Events
-
ATM Program Amendment
Myseum.AI, Inc. filed an Amendment No. 1 to its prospectus supplement, increasing the aggregate amount of common stock it intends to sell under its At-The-Market (ATM) program, which was originally established on February 6, 2026.
-
Significant Prior Sales Reported
The company has already sold 750,000 shares of common stock for gross proceeds of approximately $3.3 million since the Sales Agreement was established in February 2025.
-
Increased Offering Capacity
An additional $2,754,500 of common stock is now authorized for sale under the ATM program, significantly expanding the potential for future dilution.
Analysis
This filing provides a critical update on Myseum.AI's capital raising efforts. The company has already executed substantial dilution by selling $3.3 million worth of shares, representing a significant portion of its market capitalization. The authorization of an additional $2.75 million for sale under the At-The-Market (ATM) program indicates a continued need for capital and will likely lead to further dilution for existing shareholders. For a company of this size, these capital raises are essential for operations but also exert considerable downward pressure on the stock price due to the increased share count. Investors should monitor the pace of future sales and the company's cash burn rate.
At the time of this filing, MYSE was trading at $3.00 on NASDAQ in the Technology sector, with a market capitalization of approximately $12.7M. The 52-week trading range was $1.31 to $5.77. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.